BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17257565)

  • 1. [Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis].
    Bandrés Gimeno R; Muñoz Martínez MJ
    Arch Bronconeumol; 2007 Jan; 43(1):49-51. PubMed ID: 17257565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
    Erwin GE; Fitzgerald JE
    J Asthma; 2007 Dec; 44(10):891-5. PubMed ID: 18097869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perspectives on allergic bronchopulmonary aspergillosis].
    Germaud P; Pipet A
    Rev Mal Respir; 2007 May; 24(5):659-61. PubMed ID: 17519821
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
    Stevens DA; Schwartz HJ; Lee JY; Moskovitz BL; Jerome DC; Catanzaro A; Bamberger DM; Weinmann AJ; Tuazon CU; Judson MA; Platts-Mills TA; DeGraff AC
    N Engl J Med; 2000 Mar; 342(11):756-62. PubMed ID: 10717010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    Chishimba L; Niven RM; Cooley J; Denning DW
    J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis after the administration of itraconazole to an asthmatic patient with bronchopulmonary aspergillosis.
    Ferrari M; Bodini I; Lo Cascio V
    Respiration; 2004; 71(3):289-91. PubMed ID: 15133351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Glackin L; Leen G; Elnazir B; Greally P
    Ir Med J; 2009 Jan; 102(1):29. PubMed ID: 19284017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allergic bronchopulmonary aspergillosis].
    Hodgson U
    Duodecim; 2010; 126(4):356-63. PubMed ID: 20486486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic bronchopulmonary aspergillosis--a clinical review.
    Gupta RK; Chandr A; Gautam PB
    J Assoc Physicians India; 2012 Apr; 60():46-51. PubMed ID: 23029742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
    Grysczyk H; De Roux A; Grassot A; Mauch H; Lode H
    Dtsch Med Wochenschr; 2002 Mar; 127(10):492-6. PubMed ID: 11884987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rebound after ABPA treatment with voriconazole].
    Mulliez P; Croxo C; Saint-Georges FR
    Rev Mal Respir; 2010 Sep; 27(7):786-7. PubMed ID: 20863984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of ABPA: a place for voriconazole and omalizumab?].
    Mulliez P
    Rev Mal Respir; 2010 Sep; 27(7):670-2. PubMed ID: 20863965
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis.
    Pasqualotto AC; Powell G; Niven R; Denning DW
    Respirology; 2009 Nov; 14(8):1121-7. PubMed ID: 19909460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
    Gendrot A; de La Blanchardière A; de La Gastine B; Fromager G; Massias L; Verdon R
    Rev Med Interne; 2010 Feb; 31(2):163-6. PubMed ID: 19457596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
    Jensen SG; Nielsen TL
    Clin Respir J; 2008 Oct; 2(4):245-6. PubMed ID: 20298342
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis.
    Murphy M; Bernard EM; Ishimaru T; Armstrong D
    Antimicrob Agents Chemother; 1997 Mar; 41(3):696-8. PubMed ID: 9056016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
    Kaffarnik M; Utzolino S; Blaich A; Hopt UT
    Mycoses; 2008 Jan; 51(1):74-8. PubMed ID: 18076600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole therapy in children with cystic fibrosis.
    Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
    J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allergic broncho-pulmonary aspergillosis treated with voriconazole].
    Mulliez P; Croxo C; Roy-Saint Georges F; Darras A
    Rev Mal Respir; 2006 Feb; 23(1 Pt 1):93-4. PubMed ID: 16604033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.